Skip to main content
OpenTrials
Completed

NCT Number: NCT04279366

Biological Age Applied at Ubberup

In a previous study the investigators have developed a novel biological age model. Assessing biological age is the assessment of the present health status and functional capacity/physiological reserve of that person in comparison with people of the same age and sex.

The aim of this study is to investigate the utility and validity of this novel biological age model designed for health promotion in real world conditions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ubberup High School, Kalundborg, Danmark, Denmark

Loading trial locations.

About this study

Study design: This is a longitudinal study, where biological age assessment is conducted in the first and final week of an 11-14 week lifestyle intervention course. These courses take place at a Danish folk high school (Ubberup), which is specialized in performing intensive lifestyle interventions targeting a 10% weight loss. The intention is to include 80 adult men and women.

Data collection: This will take place at the facilities at Ubberup folk high school, participants being overnight fasted and without having exercised for the previous 24 hours. All analysis will be performed in investigators lab (Xlab) at the Department of Biomedical Sciences, Copenhagen University. When all samples are analysed Biological age will be calculated for each particpant.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participation in a long course at Ubberup folk high school (12-15 weeks)
  • Age between 18-65 years

Exclusion criteria

  • Previous or current cardiovascular disease
  • Pregnancy
  • Conditions that prevents from performing a cycle and/or strength tests

Treatment and study plan

Lifestyle Intervention

Behavioral

The 14 week courses takes place at a Danish folk high school (Ubberup), specialized in lifestyle interventions targeting a 10% weight loss. Adult individuals with obesity sign up for the course. They stay at the School for the whole course period and the total cost amounts to 300-400 Euros per week plus loss of income.

Primary outcomes

  1. Change in biological age

    Time frame: week1 and week 14

    a composite score predicting risk of lifestyle related diseases

Secondary outcomes

  1. Change in cardiorespiratory capacity

    Time frame: week 1 and week 14

    VO2max maximal oxygen consumption (ml/min/kg

  2. Change in strength

    Time frame: week 1 and week 14

    Hand grip, isometric quadriceps and biceps strength (Nm)

  3. Change in Sit to Stand test

    Time frame: week 1 and week 14

    Rise and sit from a chair as many times as possible during 1 minute (number og rises)

  4. Change in Central obesity

    Time frame: week 1 and week 14

    Waist to hip ratio is measured by dividing waist circumference with hip circumference in cm.

  5. Change in body weight

    Time frame: week 1 and week 14

    measured in kilograms

  6. Change in body composition

    Time frame: week 1 and week 14

    BMI (kg/m2) is calculated

  7. Change in fat mass

    Time frame: week 1 and week 14

    fat mass(g) is assessed by bioimpedance

  8. Change in fat percentage

    Time frame: week 1 and week 14

    Fat%, is assessed by bioimpedance

  9. Change in muscle mass

    Time frame: week 1 and week 14

    muscle mass(g) is assessed by bioimpedance

  10. Change in lipid profile

    Time frame: week 1 and week 14

    HighDensityLipoprotein (mmol/L), LowDensityLipoprofile (mmol/L), TriGlycerides (mmol/L), FreeFattyAcids (mmol/L) and Glycerol (mmol/L) is measured in a blood sample.

  11. Change in Inflammatory profile

    Time frame: week 1 and week 14

    C-reactive protein mg/L, soluble urokinase plasminogen activating receptor ng/ml, InterLeukin 6 and 8 (pg/mL), tumor necrosis factor (pg/mL), Leptin and Adiponectin (ng/ml) is analysed from blood samples

  12. Change in Blood glucose

    Time frame: week 1 and week 14

    HbA1c and fasting glucose (mmol/L) measured from blood sample

  13. Change in Respirometry

    Time frame: week 1 and week 14

    forced vital capacity and forced expiratory volume at one second(L)

  14. Change in Blood Pressure

    Time frame: week 1 and week 14

    Systolic and Diastolic blood pressure (mmHg)

  15. Change in Advanced glycation endproducts

    Time frame: week 1 and week 14

    Levels of glycated protein and lipids as a result of exposure of excess sugars advanced glycation endproducts (AGE) measured in the skin

  16. Change in Hormones

    Time frame: Week 1 and week 14

    Insulin

Other outcomes

  1. Change in Metabolic Syndrome occurrence

    Time frame: week 1 and week 14

    A cluster of 5 risk factors predicting risk of CVD and T2D

  2. Change in Framingham Risk Score

    Time frame: week 1 and week 14

    A composite score predicting 10 years risk of future CVD

Sponsors and collaborators

Lead sponsor

University of Copenhagen

Other

Collaborators

  • Technical University of Denmark

Registry information

Official study title

Evaluation and Validation of Biological Age as Health Technology

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Feb 21, 2020
Registry last updated
Feb 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.